Target intelligence / Profile preview

TIMM23B-AGAP6 readthrough (TIMM23B-AGAP6)

Target
TIMM23B-AGAP6
Molecular classification
Long non-coding RNA (lncRNA), Readthrough RNA, Non-protein coding RNA
01

Overview

This locus represents a naturally occurring *readthrough transcription event* between the adjacent genes TIMM23B (translocase of inner mitochondrial membrane 23 homolog B) and AGAP6 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 6). The resulting transcripts contain sequence portions from both parent genes but are predicted to be candidates for *nonsense-mediated decay* (NMD) and are categorized as non-coding RNA (ncRNA)[2]. There is no evidence that this readthrough transcript encodes a functional protein, nor is there evidence to support a role as a druggable or disease-associated biological target[2].\n\nKey contextual note:\n- "TIMM23B-AGAP6 readthrough" is not a conventional drug target. It is an ncRNA, specifically a readthrough product, and is not considered a receptor, enzyme, or other protein-based entity typically targeted for therapy.\n- This entity is primarily noted for its classification as a non-coding RNA with a predicted fate of rapid degradation, and not for any molecular or disease-related function.\n- Listing as a target would be incorrect, reflecting lack of substantial or actionable biological data[2].\n\nIf you need information on the protein-coding genes TIMM23B or AGAP6 individually, those *are* protein-coding genes—TIMM23B, for instance, encodes a component of the inner mitochondrial membrane protein import machinery[1][5]. This readthrough transcript, however, does not.

Other names
LINC00843long intergenic non-protein coding RNA 843TIMM23B-AGAP6
02

Biological functions

Other (predicted to undergo nonsense-mediated decay; no proven functional biological role)

Beyond the preview

Go deeper on TIMM23B-AGAP6 readthrough (TIMM23B-AGAP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TIMM23B-AGAP6 readthrough (TIMM23B-AGAP6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call